Norepinephrine Bitartrate Injection, Solution, Concentrate
Product Images NDC 72572-481

2 FDA label images from Civica, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Norepinephrine Bitartrate (NDC 72572-481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Norepinephrine Civica 01)

Chemical-structure (Norepinephrine Civica 01)
Chemical structure diagram of Norepinephrine Bitartrate showing the molecular arrangement of the organic compound and its associated bitartrate molecule with a water molecule.*
FDA Label Image

Carton (Norepinephrine Civica 02)

Carton (Norepinephrine Civica 02)
Norepinephrine Bitartrate Injection, USP 1 mg/mL (4 mg/4 mL) concentrate for intravenous infusion, labeled for single-dose vial packaging of 10 x 4 mL. The label includes warnings about potency, use instructions to dilute before use, discard unused portion, and protect from light. The product is manufactured by Civica, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.